Conclusion: The evidence supporting the use of hydroxocobalamin for shock is limited to anecdotal reports and a few cohort studies. Hydroxocobalamin appears to positively affect hemodynamics in shock, albeit similar to methylene blue.
PubMed 37147207 ↗Hydroxocobalamin
People mainly take Hydroxocobalamin for energy. Based on 6 first-hand reports and 12 meta-analyses & systematic reviews in the medical literature. Ranked #546 of 1,974 overall.
Of reports that state an outcome, 100% are positive.
What Hydroxocobalamin does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.
Conclusion: Conclusions: In adults with septic shock, adjunctive vasopressors may lower short-term death risk and likely lower kidney replacement therapy risk, but may increase risk of adverse effects. In the United States, adjunctive vasopressor use prevalence in septic shock is disconnected from the low evidence certainty for a favorable mortality-to-risk profile.
PubMed 39965613 ↗Conclusion: Recent increases in azide poisoning reports may stem from greater commercial use and availability. Treatment of systemic poisoning may require aggressive hemodynamic support due to profound hypotension. Based on mechanistic considerations, hydroxocobalamin is a rational choice for treating azide poisoning.
PubMed 34128439 ↗Conclusion: Administration of non-adrenergic vasopressors was significantly associated with reduced mortality in patients with septic shock. However, no single agent achieved statistical significance in separate analyses. Although the pooled effects of non-adrenergic vasopressors on survival did not reach statistical significance in patients undergoing cardiac or non-cardiac surgery, the confidence intervals included the possibility of both no effect and a clinically important benefit from non-adrenergic agents. These findings justify the conduct of further RCTs comparing non-adrenergic vasopressors to us
PubMed 39736782 ↗Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
Verbatim quotes, shortened only — each links to the original discussion.
“Hydroxo seems clean but I occasionally use Cyano as it's cheap”
“occasionally hydroxocobalamin ... when I want some extra energy”
“Started taking Folinic Acid and Hydroxocobalamin, noticed difference like night and day.”
“Hydroxocobalamin is tolerated by under and overmethylators”
“Hydroxocobalamin raised a lot (to 700) but i didnt felt any improvement except the day I took injection I felt tiny bit more alive”
Other options for energy
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate